I agree that this site is using cookies. You can find further informations here.
X
Pettersson, Billie
22  results:
Search for persons X
?
1

The health care experience of adults with metabolic dysfunc..:

Stine, Jonathan G. ; Medic, Nenad ; Pettersson, Billie..
Hepatology Communications.  8 (2024)  6 - p. , 2024
Link: https://doi.org/10.1097/..
 
?
2

Predicted impact of lipid lowering therapy on cardiovascula..:

Journath, Gunilla ; Hambraeus, Kristina ; Hagström, Emil..
BMC Cardiovascular Disorders.  17 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
3

Impact of symptomatic hypoglycemia on medication adherence,..:

Walz, Lotta ; Pettersson, Billie ; Rosenqvist, Ulf...
Patient Preference and Adherence.  , 2014
Link: https://doi.org/10.2147/..
 
?
4

Authors' Reply to Godman and Gustafsson: "A New Reimburseme..:

Persson, Ulf ; Svensson, Johanna ; Pettersson, Billie
Applied Health Economics and Health Policy.  11 (2013)  1 - p. 83-84 , 2013
Link: https://doi.org/10.1007/..
 
?
5

Attainment of normal lipid levels among high cardiovascular..:

Ambegaonkar, Baishali M. ; Bash, Lori D. ; Chirovsky, Diana R....
European Journal of Internal Medicine.  24 (2013)  7 - p. 656-663 , 2013
Link: https://doi.org/10.1016/..
 
?
6

The impact of pharmaceutical innovation on longevity and me..:

Lichtenberg, Frank R. ; Pettersson, Billie
Economics of Innovation and New Technology.  23 (2013)  3 - p. 239-273 , 2013
Link: https://doi.org/10.1080/..
 
?
7

The impact of pharmaceutical innovation on longevity and me.. 

evidence from longitudinal, disease-level data  CESifo working paper ; 3894, Social Protection
Lichtenberg, Frank R. ; Pettersson, Billie , 2012
Link: http://hdl.handle.net/10..
 
?
8

A New Reimbursement System for Innovative Pharmaceuticals C..:

Persson, Ulf ; Svensson, Johanna ; Pettersson, Billie
Applied Health Economics and Health Policy.  10 (2012)  4 - p. 217-225 , 2012
Link: https://doi.org/10.2165/..
 
?
9

Utilization and costs of glucose lowering therapies followi..:

Pettersson, Billie ; Hoffmann, Mikael ; Andersson, David..
Health Policy.  108 (2012)  2-3 - p. 207-215 , 2012
Link: https://doi.org/10.1016/..
 
?
10

Utilization and costs of lipid modifying therapies followin..:

Pettersson, Billie ; Hoffmann, Mikael ; Wändell, Per.
Health Policy.  104 (2012)  1 - p. 84-91 , 2012
Link: https://doi.org/10.1016/..
 
?
11

Self-reported experience of hypoglycemia among adults with ..:

Pettersson, Billie ; Rosenqvist, Ulf ; Deleskog, Anna..
Diabetes Research and Clinical Practice.  92 (2011)  1 - p. 19-25 , 2011
Link: https://doi.org/10.1016/..
 
?
12

Prevalence of lipid abnormalities before and after introduc..:

Pettersson, Billie ; Ambegaonkar, Baishali ; Sazonov, Vasilisa...
BMC Public Health.  10 (2010)  1 - p. , 2010
Link: https://doi.org/10.1186/..
 
?
13

Predicted impact of lipid lowering therapy on cardiovascula..:

Journath, Gunilla ; Hambraeus, Kristina ; Hagström, Emil..
BMC Cardiovascular Disorders, 1471-2261, 2017, 17,.  , 2017
Link: http://urn.kb.se/resolve..
 
?
14

Impact of symptomatic hypoglycemia on medication adherence,..:

Walz, Lotta ; Pettersson, Billie ; Rosenqvist, Ulf...
Patient Preference and Adherence, 2014, 8, s. 593-601.  , 2014
Link: http://urn.kb.se/resolve..
 
?
15

Impact of symptomatic hypoglycemia on medication adherence,..:

Walz, Lotta ; Pettersson, Billie ; Rosenqvist, Ulf...
info:eu-repo/semantics/altIdentifier/doi/10.2147/PPA.S58781.  , 2014
Link: https://www.dovepress.co..
 
1-15